Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter's five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1 High cases of cancer
4.1.2 Increasing investments
4.1.3 Various applications
4.2 Restraints
4.2.1Lack of reimbursement
4.3 Opportunities
4.3.1 Emerging markets offer profitable opportunities
4.4 Challenges
4.4.1.Complexities in gene structure.
Chapter 5 Asia Pacific Epigenetic Market - By Product
5.1 Reagents
5.2 Kits
5.3 Enzymes
5.4 Instruments
Chapter 6 Asia Pacific Epigenetic Market - By Technology
6.1 RNA Interference
6.2 DNA Methylation
6.3 Histone Modifications
Chapter 7 Asia Pacific Epigenetic Market - By End-User
7.1Pharmaceutical
7.2Biotechnology
7.3 Contract Research Organisation.
Chapter 8 Asia PacificEpigenetic Market - By Geography
8.1 Introduction
8.2 Asia Pacific
8.2.1. China
8.2.2. India
8.2.3. Japan
8.2.3. South Korea
8.2.5. Australia & New Zealand
8.2.6. Rest of APAC
Chapter 9 Asia Pacific Epigenetic Market - Company Profiles
9.1.Covaris Inc.
9.2.Celgene
9.3.4SC
9.4. Merck Millipore
9.5. Karus Therapeutics
9.6.Ribimed Biotechnologies
9.7.Epiontis
9.8.Eisai Co. Ltd.
9.9.Epizyme
9.10.Diagenode
9.11.Gilead Sciences Inc.
9.12.Illumina Inc.
9.13.Novartis AG
9.14.Cellcentric
9.15 Qiagen
Chapter 10 Asia PacificEpigenetic Market - Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2.Analysts Opinions
11.3.Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
